(PDF) P3.04-10 Monocytes and Neutrophils as Predictive

P3.04-10 Monocytes and Neutrophils as Predictive Markers of Response to Immune Checkpoint Inhibitors in Metastatic Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1717

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P1.04-17 Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients With Metastatic Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Cancer Research

English

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Current Treatment Options in Oncology

English

Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated With Immune‐Checkpoint Inhibitors

Cancer Research

English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

English

Immune Checkpoint Modulation for Non-Small Cell Lung Cancer

Clinical Cancer Research

Cancer Research

English

Safety and Tolerability of Extracranial Radiation Therapy and Immune Checkpoint Inhibitors Among Patients With Metastatic Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

P3.04-29 Efficacy of Re-Treatment With Immune Checkpoint Inhibitors in Patients With Pretreated Advanced Non-Small Cell Lung Carcinoma

Journal of Thoracic Oncology

Respiratory Medicine

English

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

English